Product
RZ358
1 clinical trial
1 indication
Indication
Congenital HyperinsulinismClinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy and Safety of RZ358 in Patients With Congenital HyperinsulinismStatus: Recruiting, Estimated PCD: 2025-04-04